Health-related quality of life in Parkinson’s: impact of ‘off’ time and stated treatment preferences
- 1 December 2015
- journal article
- research article
- Published by Springer Nature in Quality of Life Research
- Vol. 25 (6) , 1505-1515
Abstract
Purpose Long-term levodopa therapy and related fluctuating plasma concentrations are associated with between-dose periods of ‘off time’ resulting in substantial variation in symptoms and functioning throughout the day in people with Parkinson’s (PwP). Methods PwP across UK, France, Spain and Italy completed an online survey to explore: the impact of ‘off time’ on (1) health-related quality of life (HRQL) and (2) on functioning and ability to undertake usual activities; (3) the value of ‘off time’ relative to other factors associated with Parkinson’s through a stated preference discrete choice experiment (SPDCE). Results In total, 305 PwP completed the online survey. Overall mean HRQL (utility) score was significantly lower for ‘off time’ (0.37) than for ‘on time’ (0.60). All attributes within the SPDCE were significant predictors of treatment choice, although increased duration of ‘on time’ (per hour per day: odds ratio (OR) = 1.40) and predictability of ‘off time’ to within 30 min (OR = 1.42) were valued most highly. Conclusions ‘On time’ and predictability of ‘off time’ are highly valued by PwP. Due to substantial diurnal variation of Parkinson’s symptoms, standard patient-reported outcome (PRO) assessments may not adequately capture the impact of ‘off time’ on HRQL and participation in daily activities.Keywords
Funding Information
- GlaxoSmithKline
This publication has 34 references indexed in Scilit:
- Patient perspectives on Parkinson’s disease therapy in Japan and the United States: results of two patient surveysPatient Related Outcome Measures, 2012
- Wearing‐off scales in Parkinson's disease: Critique and recommendationsMovement Disorders, 2011
- Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)Quality of Life Research, 2011
- Living with advanced Parkinson’s disease: a constant struggle with unpredictabilityJournal of Advanced Nursing, 2010
- Conducting Discrete Choice Experiments to Inform Healthcare Decision MakingPharmacoEconomics, 2008
- Estimation of minimally important differences in EQ-5D utility and VAS scores in cancerHealth and Quality of Life Outcomes, 2007
- Patient preferences for asthma therapy: a discrete choice experimentPrimary Care Respiratory Journal, 2007
- Recombinant Erythropoietin for Chemotherapy-Related AnaemiaPharmacoEconomics, 2007
- The levodopa wearing-off phenomenon in Parkinson’s disease: pharmacokinetic considerationsExpert Opinion on Pharmacotherapy, 2006
- Using thematic analysis in psychologyQualitative Research in Psychology, 2006